Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm

BACKGROUND: Fluoropyrimidine chemotherapy [5-fluorouracil (5-FU) and capecitabine] are commonly used agents in the treatment of various solid malignancies. However, their use has been limited by cardiac toxicity, presenting as a wide spectrum of asymptomatic (e.g., EKG changes) and symptomatic (e.g....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gastrointest Oncol
Autori principali: Clasen, Suparna C., Ky, Bonnie, O’Quinn, Rupal, Giantonio, Bruce, Teitelbaum, Ursina, Carver, Joseph R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750187/
https://ncbi.nlm.nih.gov/pubmed/29299356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.09.07
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi